Hsbc Holdings PLC Tarsus Pharmaceuticals, Inc. Transaction History
Hsbc Holdings PLC
- $168 Billion
- Q3 2024
A detailed history of Hsbc Holdings PLC transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 6,459 shares of TARS stock, worth $349,690. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,459
Previous 9,067
28.76%
Holding current value
$349,690
Previous $246,000
13.82%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding TARS
# of Institutions
172Shares Held
43.5MCall Options Held
484KPut Options Held
4.1K-
Rtw Investments, LP New York, NY3.41MShares$185 Million1.79% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$177 Million0.0% of portfolio
-
Jennison Associates LLC2.5MShares$135 Million0.09% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.44MShares$132 Million2.89% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$122 Million6.32% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.44B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...